• events
  • News and Community
  • Content by Category
    • Artificial Intelligence in Health Tech
    • Medical Cloud Computing
    • Patient Engagement
    • EHR/EMR
    • Telehealth
  • Our Network
    • IT Tech News
    • CXO Insiders
    • Rev Tech News
    • Fin Tech News
    • HR Tech News
    • Client Papers
    • Soc News
    • Martech-News
  • events
  • News and Community
  • Content by Category
    • Artificial Intelligence in Health Tech
    • Medical Cloud Computing
    • Patient Engagement
    • EHR/EMR
    • Telehealth
  • Our Network
    • IT Tech News
    • CXO Insiders
    • Rev Tech News
    • Fin Tech News
    • HR Tech News
    • Client Papers
    • Soc News
    • Martech-News
Login
  • events
  • News and Community
  • Content by Category
    • Artificial Intelligence in Health Tech
    • Medical Cloud Computing
    • Patient Engagement
    • EHR/EMR
    • Telehealth
  • Our Network
    • IT Tech News
    • CXO Insiders
    • Rev Tech News
    • Fin Tech News
    • HR Tech News
    • Client Papers
    • Soc News
    • Martech-News
  • events
  • News and Community
  • Content by Category
    • Artificial Intelligence in Health Tech
    • Medical Cloud Computing
    • Patient Engagement
    • EHR/EMR
    • Telehealth
  • Our Network
    • IT Tech News
    • CXO Insiders
    • Rev Tech News
    • Fin Tech News
    • HR Tech News
    • Client Papers
    • Soc News
    • Martech-News
Login

News and Community

DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate

Astrazeneca, Daiichi Sankyo, Datroway, Metastatic Triple-negative Breast Cancer, Tropion-breast02, Us Food And Drug Administration

  • May 25, 2026

FDA Approves DATROWAY in the US as First TROP2-directed Antibody Drug Conjugate for Unresectable or Metastatic Triple-Negative Breast Cancer (TNBC)

PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b

Clinical Tria, Eha2026, Essential Thrombocythemia, Pharmaessentia, Polycythemia Vera, Ropeginterferon Alfa-2b

  • May 25, 2026

PharmaEssentia Announces New Clinical Data for Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026

eClinicalWorks and healow Genie Help Capital Area Health Network Transform Patient Call Experience, Eliminating 45-Minute Wait Times

Ai-powered Contact Center Solution, Capital Area Health Network, Eclinicalworks, Federally Qualified Health Center, Healow Genie, Patient Scheduling

  • May 22, 2026

eClinicalWorks Help FQHC and CAHN Implement healow Genie, an AI-Powered Contact Center Solution to Transform Patient Call Experience

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy

Artificial Intelligence System, Cardiac Mri Scan, Carnegie Mellon University, Cleveland Clinic, Cmr-clip, Medical Ai

  • May 22, 2026

Carnegie Mellon University and Cleveland Clinic Create Artificial Intelligence System to Interpret Cardiac MRI Scans with High Accuracy

WellSky® and Unison Health Services

Ai-powered Home Healthcare Innovation, Electronic Medical Record, Unison Health Services, Wellsky Home Health Ehr, Wellsky Skysense Ai

  • May 21, 2026

WellSky and Unison Health Services, Inc. Partner to Advance AI-Powered Home Healthcare Innovation

TruBridge Signs CMS Health Tech Ecosystem Pledge as Nation’s Leading Rural Healthcare Platform

Centers For Medicare & Medicaid Services, Cms Health Tech Ecosystem Pledge, Electronic Prior Authorization, Healthcare Organizations, Healthcare Providers, Rural Healthcare

  • May 21, 2026

TruBridge Commits to CMS Health Tech Ecosystem Pledge as Nation’s Dedicated Voice for Rural Health Providers

Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise

Agentic Ai, Anthropic Claude, Bristol Myers Squibb, Clinical Trial, Frontier Artificial Intelligence, Shared Intelligence Platform

  • May 21, 2026

Bristol Myers Squibb Selects Anthropic Claude as the Shared Intelligence Platform Across Its Global Operations

Nourish Raises $100M Series C to Reverse Chronic Disease with AI-Native Metabolic Clinic

Ai-native Metabolic Clinic, Chronic Disease, Metabolic Health Clinic, Nourish, Sustained Nutrition Support, U.s. Healthcare

  • May 20, 2026

Nourish Secures $100 Million Series C Investment to Reverse Chronic Disease with AI-Native Metabolic Clinic

Incyte and Edison Scientific Announce Strategic Collaboration

Biopharma Industry, Biopharmaceutical Innovation, Edison Scientific, Incyte, Kosmos Ai Platform, Translational Biology

  • May 20, 2026

Incyte and Edison Scientific Announce Partnership to Employ Kosmos AI Platform for Research and Development

Load More
Load More

At healthtechinsiders.com we deliver the latest insights and trends in Enterprise IT and Cloud transformation, empowering IT leaders and professionals to make informed decisions in a fast-evolving digital world.

 

Quick Links

  • About Us
  • Contact us
  • Publisher Sites
  • Events
  • News & community

TOP Categories

  • Artificial Intelligence in Health Tech
  • Medical Cloud Computing
  • Patient Engagement
  • EHR/EMR
  • Telehealth

Subscribe

Linkedin

@2026 HealthTech Insiders or its affiliates – All rights reserved.

Privacy Policy | GDPR | CCPA